Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company reported a decrease in net profit for the third quarter of 2024, with a 37.82% drop compared to the same period in 2023, despite a slight increase in total assets and equity. Operating income saw a marginal decrease of 1.08% for the quarter, while net cash flow from operating activities plummeted significantly. Investors should note the company’s mixed financial performance as they assess its future prospects.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
